
Praveen Kumar Marimuthu/X
Mar 26, 2025, 03:52
Praveen Kumar Marimuthu: Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III NSCLC
Praveen Kumar Marimuthu, DM Resident – Medical oncology at Christian Medical College and Hospital, shared a post on X:
” ‘When Less Is Truly More’
Excited to share our work from Med Onc CMC Vellore published in JCO Global Oncology.
‘Does adding low dose Nivo to NACT response rates and survival in stage III non-oncogene-driven NSCLC?’
Mentor – Ashish Singh
Key findings.”
Authors: Praveen Kumar Marimuthu et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22